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Case Presentation
A 46-year-old male surgical pathologist pre-
sented to our clinic complaining of a 4-year
history of increasing shortness of breath. He
had been in good health until 20 years prior
while in medical school, when he noted a pru-
ritic, erythematous rash on the dorsal aspect of
his hands whenever he wore latex gloves. He
often applied steroid cream to the rash, but it
usually did not resolve unless he refrained from
using latex gloves. This rash, associated with
latex glove use, persisted during his internal
medicine residency. Approximately 14 years
before presentation, at the beginning of his
pathology residency, he noted that the rash
involved his arms. He developed an episodic,
nonproductive cough, wheezing, and occa-
sional chest tightness, which occurred at work
when he used powdered latex gloves. These
symptoms were mild and did not interfere
with his vigorous exercise program. He did not
seek medical attention.
After completing his residency, the
patient worked as a hospital-based surgical
pathologist. Typical daily activities involved
cutting tissue and frozen sections and pre-
paring slides. He changed gloves several times
each day. He did reasonably well until 4 years
before presentation (1993), when his symp-
toms worsened. He then experienced cough
and dyspnea within 30 min of starting work.
These symptoms, which continued through-
out the workday and improved once he left
work, seemed especially severe on the ﬁrst day
of the workweek and worsened as the week
progressed. The use of xylene and formalde-
hyde exacerbated his symptoms. He noted an
intermittent rash on his upper extremities and
torso, occasional flushing with exposure to
latex, postnasal drip, progressive dyspnea on
exertion, and dyspnea and coughing when he
laughed. He noted heavy breathing if he
“ﬂipped” his gloves off, and he described an
episode of “passing out” 1 year earlier when
he “flipped” his gloves off and placed his
hands over his mouth and nose. He was taken
to a local emergency department, where he
was diagnosed as having had a vasovagal
episode. He was returned to work without
intervention.
The patient’s wife and co-workers started
commenting on his cough, noting that he
“breathed heavily.” He became self-conscious
about his cough and about constantly having
to clear his throat. There was no seasonal varia-
tion to his symptoms. The patient attempted
to reduce his exposure to powdered natural
rubber latex (NRL) gloves, formaldehyde, and
xylene. For example, he switched to non-
powdered latex gloves, although his co-workers
continued to use the powdered form. He
replaced eyecups on the microscope once he
realized that they contained latex. He
instructed his staff to allow an hour for drying
slides fixed with formaldehyde and xylene
before sending them to him to be read. His
symptoms persisted, however, prompting him
to seek medical attention.
The patient subsequently consulted with
an allergist, an otorhinolaryngologist, and a
dermatologist. Skin biopsy of his rash revealed
changes consistent with acute urticaria. Latex
skin prick tests were positive to latex glove
extracts. Skin prick tests were positive to dust,
cat dander, and mold antigens, and a com-
puterized tomography (CT) scan of the sinuses
revealed nasal polyps in the maxillary sinus. He
was diagnosed with chronic sinusitis, asthma,
and allergic rhinitis. Treatment included
antibiotics and a steroid taper. The patient
was started on Serevent (GlaxoSmithKline,
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CONTEXT: Latex allergy and sensitization have been an important problem facing health care
workers. Providing a latex-safe environment is the intervention of choice. 
CASE PRESENTATION: A 46-year-old surgical pathologist presented with increasing shortness of
breath for the previous 4 years. Twenty years before presentation, he noted a pruritic, erythematous
rash on his hands, associated with latex glove use. Fourteen years before presentation, during
pathology residency, he developed a nonproductive cough, wheezing, and an urticarial rash, tempo-
rally associated with use of powdered latex gloves. These symptoms improved while away from
work. At presentation, he had one-ﬂight dyspnea. His skin prick test was positive for latex, and pul-
monary function testing showed mild obstruction, which was reversible with bronchodilator use.
Because the patient was at risk for worsening pulmonary function and possible anaphylaxis with
continued exposure, he was removed from the workplace because no reasonable accommodation
was made for him at that time. 
DISCUSSION: The patient’s presentation is consistent with latex-induced occupational asthma.
Initially noting dermal manifestations, consistent with an allergic contact dermatitis secondary to
accelerators present in latex gloves, he later developed urticaria, ﬂushing, and respiratory symptoms,
consistent with a type I hypersensitivity reaction to latex. He also has reversible airways disease,
with signiﬁcant improvement of peak expiratory ﬂow rate and symptoms when away from work. 
RELEVANCE TO CLINICAL OR PROFESSIONAL PRACTICE: The ideal treatment for latex sensitization is
removal from and avoidance of exposure. Clinicians should consider occupational asthma when
patients present with new-onset asthma or asthmatic symptoms that worsen at work. 
KEY WORDS: formaldehyde, health care worker, latex allergy, occupational asthma, pathology, xylene.
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(GlaxoSmithKline), and Proventil (Schering,
Kenilworth, NJ) inhalers and returned to
work with the recommendation that he use a
surgical mask while at work. His symptoms
continued to progress, and he presented to us
2 months later, by which time he was experi-
encing single-ﬂight dyspnea.
The patient’s past medical history was
remarkable for hypertension, nasal polyps, and
near syncope. He denied any previous diagno-
sis of asthma, allergy, hives, or anaphylaxis.
His family history was remarkable for asthma
in a sister and a paternal uncle. He denied use
of alcohol, cigarettes, or illegal drugs and
denied allergies to medications or environ-
mental substances. He gave a history of chest
tightness when he ate fruit such as banana,
avocado, and kiwi. His occupational history
was remarkable for work in the medical ﬁeld
(Table 1). On physical examination, he was a
well-nourished, well-developed white male in
no acute distress whose vital signs were within
normal limits. His examination was remark-
able for a body mass index of 30, hyperemic
conjunctivae, boggy nasal mucosa, an erythe-
matous urticarial rash on his right shoulder,
and diffuse expiratory wheezing.
Laboratory evaluation revealed a normal
electrocardiogram. Chest X ray showed poor
inspiration; CT of the chest showed mild
bronchial wall thickening consistent with
mild airways disease; pulmonary function
tests (PFTs) were remarkable for mild obstruc-
tion with acute bronchodilator response
(Table 2); and a radioallergoimmuno-
absorbent assay (RAST) test for latex IgE
antibody was negative. His peak expiratory
flow rate (PEFR) diary during an 11-day
work period and a subsequent 6-day vacation
period showed signiﬁcant improvement (20%
in the morning, 22% in the evening) while he
was away from work (Table 3) and progres-
sive improvement during successive days of
vacation (Figure 1).
The provision of a latex-safe environment
was explored with hospital administration and
deemed not feasible at that time. A full-face
dual-cartridge respirator was recommended
and tried in consultation with a certified
industrial hygienist. However, it interfered
with the patient’s ability to communicate, and
he was unable to tolerate wearing it for an 8-hr
day. We felt that he was at risk for potentially
fatal anaphylaxis, as well as irreversible and
impending structural damage to his lungs,
given his long history of exposure and disease
severity. In order to eliminate exposure to
NRL, the patient was removed from the work-
place. He was advised to avoid contact with
latex, carry injectable epinephrine, and wear a
MedicAlert bracelet (MedicAlert Foundation
International, Turlock, CA). Despite removal
from the workplace shortly after presentation,
the patient’s pulmonary status did not
improve. He is maintained on steroids and
immunosuppressive agents and has not been
able to return to work as a surgical pathologist.
Discussion
Latex allergy and sensitization. The use of
powdered high-protein NRL gloves is recog-
nized as the major environmental risk factor
for latex sensitization and allergy in the health
care field (Levy et al. 1999; Wild and Lopez
2003). The widespread use of NRL gloves in
the health care industry started in the 1980s as
health care facilities complied with Universal
Precautions [Occupational Safety and Health
Administration (OSHA) 1991]. After the ﬁrst
report of a case of immediate hypersensitivity
to NRL (Nutter 1979), NRL allergy became
increasingly recognized as a problem among
health care workers (Garabrant and Schweitzer
2002). NRL, used in the production of latex
gloves, is derived from the milky sap of the
commercial rubber tree, Hevea brasiliensi
(Atkins 1999). The sap of this tree is a complex
mixture of protein, lipid, and phospholipid.
The protein content varies depending on
country of harvest location, environmental
conditions, and manufacturing process. Sixty
of the 240 proteins in NRL have been found
to be allergenic (Levy et al. 1999).
Freshly harvested latex is treated with
ammonia and other preservatives to prevent its
deterioration during transport to factories; it is
then treated with antioxidants and accelerators
before being shaped into the final product.
Increased washing time in glove manufacture
can lead to a decrease in the amount of soluble
protein in the ﬁnal product (Yunginger et al.
1994), hence decreasing the antigenicity of the
glove. The product is frequently dry-lubricated
with cornstarch or talc powder to improve ease
of donning the glove. Latex allergen elutes onto
the powder, providing a source for respiratory
exposure (Yunginger et al. 1994). Notably,
synthetic rubber elastomers (butyl rubber, poly-
mers of 2-chlorobutadiene, co-polymers of
butadiene and acrylonitrile) do not cause or
contribute to allergic sensitization; people who
are sensitized to NRL proteins can safely use
products made from synthetic rubbers (OSHA
1999; Renaud 1993).
Most reactions associated with NRL can
be classiﬁed into three main categories: irritant
contact dermatitis (ICD), allergic contact der-
matitis (ACD), and an immediate hyper-
sensitivity reaction (Felt-Ahmed et al. 2003).
ICD is conﬁned to the skin and occurs when
the skin has direct contact with the glove.
ICD represents a type of contact dermatitis
and is not allergic in nature. The second type
of reaction, ACD, is a delayed hypersensitivity
reaction (type IV) thought to be a result of
exposure to the accelerators, which can lead to
the activation and release of lymphokines by
sensitized T lymphocytes rather than to the
latex itself (Atkins 1999). Endotoxins, which
may be present as contaminants, have also
been implicated as causing ACD (Charous
et al. 1997). Features of ACD are pruritic
rash, local erythema, swelling, blistering,
weeping, and crusting. These symptoms gen-
erally occur 1–2 days after exposure but also
may occur from several hours to several days
postexposure (Felt-Ahmed et al. 2003).
The third type of reaction, the type I,
immediate-type hypersensitivity reaction,
relies on previous sensitization of the immune
system to latex antigens and to the generation
of IgE antibodies directed speciﬁcally at latex
proteins and is the most serious of the three
(Atkins 1999; Vandenplas et al. 1995). Signs
and symptoms include asthma, rhinitis, con-
junctivitis, generalized urticaria, and mucous
membrane swelling. Anaphylaxis, the most
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Table 1. The chronological relationship between the patient’s occupational exposure and the appearance
of symptoms.
Year Occupation Symptoms
1977 Medical student Rash on dorsum of hands with latex glove use; does not clear with steroid use
1979 Internal medicine resident Continued rash on dorsum of hands with latex glove use
1984 Pathology resident Rash on hands and arms, urticaria, wheezing, chest tightness, chronic cough
1987 Surgical pathologist Diagnosed with nasal polyps
1993 Surgical pathologist Notes dyspnea within 30 min of work and with coughing and laughing
1996 Surgical pathologist Allergist evaluation results in diagnosis of asthma and allergic rhinitis; 
emergency department evaluation results in diagnosis of “near syncope” 
after he ﬂipped off gloves and covered mouth and nose with hands
1997 Surgical pathologist Presents to our clinic with single ﬂight dyspnea; removed from workplace 
because no reasonable accommodation made at work
Table 2. Spirometry results before and after bronchodilator use showing FEV1 and FVC.
Percent Percent  Percent 
Prebronchodilator predicted Postbronchodilator predicted change
FEV1 (L) 2.65 67 2.98 75 13
FVC (L) 3.96 81 4.47 91 13
FEV1/FVC 67 — 67 — —
Abbreviations: FEV1, forced expiratory volume in 1 sec; FVC, forced vital capacity.dreaded complication, may also occur in a
sensitized patient and has been recorded to
have occurred as a result of donning gloves,
being in the presence of others who have put
on gloves, during surgery, and during dental
and medical examinations (Vandenplas et al.
1995). In 1991, a latex barium enema tip
associated with 16 deaths was recalled by the
Food and Drug Administration (FDA); this
led to an increased awareness of the risk of life-
threatening type I allergy associated with NRL
devices (Gelfand 1991). Sensitization occurs
after multiple exposures over a highly variable
time, the latency period ranging from several
weeks to as long as 30 years (Malo et al.
1992). Once sensitization occurs, there is con-
siderable variability in the type and severity of
allergic symptoms, occurring from within
30 min (anaphylaxis, angioedema) to more
than hours and days after exposure. Asthma
symptoms are highly variable in their onset,
duration, and intensity, the more severe cases
being associated with multiple and prolonged
exposures occurring over many months to
years (Felt-Ahmed et al. 2003).
The prevalence of latex sensitization has
been estimated to be between 5 and 17% in
health care workers (Malo et al. 1992), versus
between 5 and 10% in the general population
(Felt-Ahmed et al. 2003). The factors associ-
ated with an increase in the risk of latex sensi-
tization among health care workers include
the duration of exposure and the intensity of
exposure to NRL gloves. Intensity of exposure
is measured by the number of pairs of gloves
used per day and the amount of powdered
glove use (Garabrant and Schweitzer 2002).
The mechanical and irritant reaction to the
powder may lead to a breakdown of the skin
barrier, further enhancing exposure to the latex
protein (Levy et al. 1999). In addition, the
powder disseminates into the environment,
carrying the latex protein with it, providing a
respiratory route of exposure (Baur et al.
1993). An increase in latex sensitization is seen
with particular jobs and departments in health
care probably as a result of a relatively higher
exposure to NRL gloves. Laboratory workers
have been found to have the highest incidence
of latex sensitization, 4% per year, whereas the
incidence of latex sensitization among health
care workers in general has been estimated at
1–2.5% per year; pathology staff has been
found to have a 14% prevalence of latex sensi-
tization (Garabrant and Schweitzer 2002).
Atopic individuals are more easily sensi-
tized to allergens and, as such, are at greater
risk of developing a latex allergy than are indi-
viduals who are not atopic (Felt-Ahmed et al.
2003). Atopy is a hypersensitivity state or
allergy with hereditary predisposition. Atopic
individuals may have a personal or family his-
tory of eczema, asthma, or hay fever or a ten-
dency to develop speciﬁc IgE antibodies after
exposure to common environmental sub-
stances, although many do not. The tendency
to develop some form of allergy is inherited,
but the specific clinical form, such as hay
fever, asthma, or eczema, is not (Wild and
Lopez 2003). Skin tests to common environ-
mental allergens such as pollen, animal dan-
der, molds, and house dust mites are used to
evaluate atopic status. One looks for the
immediate IgE-mediated wheal and ﬂare reac-
tion. Clinical associations have been reported
between latex allergy and allergy to several
fruits and vegetables, such as avocado, kiwi
fruit, banana, potato, tomato, chestnut, and
papaya (Beezhold et al. 1996). Several latex
allergens (e.g., Heb b2, 5, 6.02, and 7) have
varying degrees of amino acid sequence
homology with allergens in seed-producing
plants (Wagner and Breiteneder 2002). Some
patients report that food allergy preceded the
latex allergy, and others report the converse
(Beezhold et al. 1996). 
Sensitization can be documented by the
use of a skin prick test using extracts prepared
from suspected substances, such as latex, in the
work environment. Detection of speciﬁc IgE
antibodies suggests a cause-and-effect relation-
ship. Licensed extracts of latex for skin testing,
available in Europe, have been found to be safe
and reliable for detecting latex-specific IgE.
The United States does not have licensed com-
mercial latex extracts. As a result, skin testing is
done with unstandardized ofﬁce-prepared latex
extracts, which vary widely in allergen content
(Ownby 2003). Specific IgE antibodies can
also be studied in vitro using a blood test, the
RAST assay (Wild and Lopez 2003). Tests for
latex-specific IgE such as the RAST are less
sensitive and speciﬁc than are skin prick tests,
with sensitivity ranging between 73 and 80%
and speciﬁcity ranging between 90 and 97%
(Ownby 2003). The laboratory to which this
patient’s RAST was sent reports a 30% false-
negative rate (Hamilton 1999).
Latex-induced occupational asthma.
Occupational asthma (OA) can be deﬁned as
the presence of variable airflow obstruction
and bronchial hyperresponsiveness caused by
a substance found in the workplace (Tilles
and Jerath-Tatum 2003). OA differs from
preexisting asthma, which is exacerbated by
exposure to agents in the workplace (Wild
and Lopez 2003). However, OA may occur in
conjunction with preexisting asthma, because
OA involves the new onset of sensitization to
a workplace antigen or allergen with the
development of respiratory disease. A person
with preexisting asthma and allergies may
develop OA to a workplace allergen. Another
feature of OA is the occurrence of nasal, ocu-
lar, or contact urticarial symptoms that pre-
cede asthma symptoms. The presence of these
symptoms is helpful, but not necessary, in
establishing the diagnosis.
Other features include the association of
prolonged exposure with worsening asthma
symptoms at work, the development of more
pervasive symptoms while at work, and the
presence of a latency period between the initial
exposures to the inciting agent where symp-
toms may develop from weeks to > 20 years
after exposure (Chan-Yeung 1987; Tilles and
Jerath-Tatum 2003; Wild and Lopez 2003).
Reactive airways dysfunction syndrome
(RADS) is a form of OA that does not require
a latency period. RADS can occur acutely,
within 24 hr, after one single exposure to an
irritant (Tilles and Jerath-Tatum 2003). OA
symptoms may resolve in some individuals,
whereas others remain symptomatic for years.
Approximately 10% of adult asthma cases are
attributed to an occupational etiology (Blanc
and Toren 1999). More than 250 agents
encountered in the workplace have been
shown to induce asthma in susceptible indi-
viduals (Wild and Lopez 2003).
Atopic individuals are at greater risk of
developing OA, especially when working in
an industry where high-molecular-weight
proteins such as latex proteins are present.
Other high-molecular-weight proteins known
to cause OA are flour and animal antigens
(Wild and Lopez 2003). Allergic OA is seen
in individuals who develop sensitization to a
specific chemical agent in the workplace.
Green-McKenzie and Hudes
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Table 3. Mean morning and evening PEFRs while at work and during vacation, measured in the morning
and in the evening at bedtime both before using asthma medication.
Mean PEFR Percent
Time Work Vacation increase
Morning (L/min) 368 443 20
Evening (L/min) 361 441 22
Percent increase –2 –0.5 —































Figure 1. The patient’s morning and evening PEFRs
recorded in 1997 on 11 consecutive days while at
work (Sunday, 2 November, through Wednesday,
12 November) and on 6 consecutive days while on
vacation (Wednesday, 13 November, through
Tuesday, 18 November).Persons with allergic OA tend to develop
bronchospasm and airway inﬂammation upon
exposure, even to low concentrations of the
speciﬁc workplace agent to which they are sen-
sitized (Paggiaro et al. 1994). NRL-induced
OA, an IgE-mediated process, is initiated
when the allergen-bearing particles deposit
onto the mucosal surfaces of the respiratory
tract. Of the health care workers estimated to
be sensitized to latex, 41–69% of them are
estimated to have respiratory symptoms with
exposure (Lagier et al. 1992).
Various criteria are used in making the
diagnosis of OA. A significant postbroncho-
dilator response is considered to have occurred
if PFTs demonstrate an increase in forced vital
capacity (FVC) or forced expiratory volume in
1 sec (FEV1) of 12% above baseline and an
absolute change of 0.2 L (American Thoracic
Society 1991). Methacholine challenge testing,
the gold standard for establishing the diagnosis
of asthma, can also be used to show non-
speciﬁc bronchial hyperreactivity. An abnormal
test result is defined by the concentration of
methacholine that drops the baseline FEV1 by
20% (Tan and Spector 2003). Medical and
work histories may be used to help ascertain a
temporal association between the patient’s
symptoms and work, as well as to rule out
other causes for the symptoms.
One recommendation for conﬁrming the
diagnosis of OA, using pre- and postshift
spirometry or PEFR, is by showing a signiﬁ-
cantly decreased obstructive pattern at work
compared with being away from work. For
example, the PEFR should be measured
approximately every 2–3 hr during a 2-week
period at work and during a 1–2 week period
away from work. OA is conﬁrmed by ﬁnding
a ≥ 20% reduction in PEFR at work versus
away from work or by ﬁnding at least a 20%
diurnal variability of mean work PEFR, with
the disappearance of this variability when
away from work (Tilles and Jerath-Tatum
2003). PFTs are most useful in suggesting an
occupational cause for asthma when they
show a decrease in FEV1 of at least 15% when
comparing results obtained before and after a
period of work (Greaves 2003). The diagnosis
of OA is usually conﬁrmed by a combination
of findings. The history and physical exam
should be consistent with this diagnosis;
spirometry or methacholine challenge testing
should demonstrate variable airﬂow obstruc-
tion; and serial peak ﬂows should conﬁrm that
bronchial hyperreactivity is triggered by work-
place exposures to speciﬁc agents.
Role of formaldehyde and xylene. Formal-
dehyde is an upper respiratory tract irritant,
exacerbating bronchial airﬂow obstruction or
hyperreactivity. It can exacerbate asthma and
precipitate wheezing in those with under-
lying asthma or bronchial hyperreactivity.
Formaldehyde may cause an immune response
by forming a hapten, a complex of a protein
and a low-molecular-weight compound, which
can induce an IgE response, although this is
uncommon (Rutchik 1999). Xylene, an aro-
matic hydrocarbon used in medical technology
as a solvent and fixative, may exacerbate
asthma and rhinitis. Other agents to which
our patient may have been exposed during his
daily work as a pathologist that he did not
identify as speciﬁc triggers to his symptoms—
but that are associated with respiratory and
dermatologic symptoms—are glutaraldehyde,
phenol, and ethylene glycol (Rutchik 1999).
Treatment and workplace accommodation.
Disability from occupationally induced allergies
is compensable under Workers’ Compensation
law (Phillips et al. 1999). A worker with OA or
NRL-induced anaphylaxis is considered to be
100% impaired from performing his or her
speciﬁc job if the job entails exposure to the
causative agent (American Thoracic Society
1993; Bernstein 2002). Under the Americans
with Disabilities Act (1990), reasonable work-
place accommodation must be made to allow
a disabled worker to perform the “essential
functions” of the job. The ideal treatment for
latex sensitization is prevention of exposure,
best achieved by identifying and removing all
latex-containing products in the workplace.
Latex aeroallergen levels are significantly
reduced when medical centers eliminate pow-
dered NRL gloves from the work environ-
ment, replacing them with nonpowdered
synthetic rubber gloves (Swanson et al. 1994).
This workplace modiﬁcation has been found
to be most effective and is associated with an
improvement in respiratory and dermatologic
symptoms in health care workers and with a
reduction in the number of new cases of latex
sensitization and allergy (Bernstein et al. 2003;
Hunt et al. 2002; Saary et al. 2002; Swanson
et al. 1994). It has also been shown to be cost-
effective, considering the cost incurred by dis-
ability from latex allergy and asthma (Allmers
et al. 2002; Phillips et al. 1999).
Many medical devices and products, as
well as many common household and every-
day items, contain NRL. However, identify-
ing latex-containing products was made
simpler when the FDA mandated that all
NRL-containing medical devices be labeled as
such and that health care sites provide non-
latex-containing alternatives (FDA 1997).
The FDA concluded that this intervention is
affordable for manufacturers (FDA 1997).
Extensive lists of NRL-containing products
and latex-safe alternatives are also available
(Spina Bifida Association of America 2004).
Despite this, however, it is difﬁcult to render
and maintain an environment completely
latex-free. Furthermore, NRL-containing
items may also be inadvertently brought
into an area. As a result, “latex-safe” is the
preferred term.
Prevention of exposure may also be carried
out through engineering and industrial hygiene
controls and through the use of personal pro-
tective equipment. Latex aeroallergen levels
may be monitored, and engineering controls
can include exhaust ventilation equipment
(Reiter 2002), although the use of a laminar
flow glove-changing station has not been
shown to reduce latex aeroallergens (Swanson
et al. 1994). Work-practice controls, such as
cleaning the area, might help to eliminate or
minimize the hazard. Environmental controls
such as HEPA-filtered vacuuming and wet
wiping of surfaces with isopropyl alcohol may
reduce latex allergen on surfaces (Reiter 2002).
The worker may also use personal pro-
tective equipment such as a respirator.
Respirators can provide additional protection
and mitigate the hazard but are not the
method of choice for controlling exposures.
There are various categories of respirators.
Air-purifying respirators may use negative
pressure (the user pulls air through the respi-
rator), or air is supplied through a powered
source (powered air-purifying respirator).
They remove much of the toxicant from the
inhaled air by filtration, adsorption, or
absorption. Atmosphere-supplying respira-
tors, such as the self-contained breathing
apparatus (supplies air from a source such as a
tank carried by the user), and the airline respi-
rator (uses air supplied via a hose from a dis-
tant source), provide air from an independent
source as opposed to purifying ambient air.
Most respirators require a tight seal
between the mask and the user’s face, although
some are loose ﬁtting. Masks are quarter, half,
or full face depending on the portion of the
face that is covered [Harber et al. 2005;
National Institute for Occupational Safety and
Health (NIOSH) 2005]. Laminar ﬂow HEPA-
ﬁltered helmets have been found to be effective
in reducing the symptoms of latex-induced
asthma, rhinitis, and conjunctivitis (Laoprasert
et al. 1998). Respirators may interfere with
vision, hearing, mobility, ability to communi-
cate, and the use of tools such as stethoscopes
and microscopes. They may be uncomfortably
warm, with tight-ﬁtting head straps, and may
also lead to increases in resistance to breathing,
dead space, and physical load. These factors,
among others, may contribute to a functional
inability to keep the respirator on for more
than a brief period of time in some persons.
Recommendations of a certified industrial
hygienist should be used when available
(Harber et al. 2005; NIOSH 2005).
Sensitized workers with severe asthma and
other life-threatening allergic reactions must be
removed from the workplace if exposure can-
not be prevented, because the asthmatic
response can occur at minute levels of exposure
(Ehrlich 1994). Although not documented in
individuals with OA due to NRL, evidence
Latex-induced occupational asthma
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red cedar asthma and toluene diisocyanate,
indicates that repeated exposures to the incit-
ing agent can increase the severity of the
asthma, and the disease process may even
progress after removal from exposure (Banks
et al. 1990; Butcher et al. 1982; Chan-Yeung
et al. 1982; Cote et al. 1990). Ultimately, irre-
versible lung damage and death can result
from repeated exposure (Banks et al. 1990;
Chan-Yeung 1987).
Removing the employee from the work-
place has personal, social, and economic impli-
cations. The latex-allergic health care worker
may experience psychological distress sec-
ondary to coping with the adjustment and may
respond with anger, depression, anxiety, and
denial. Self-esteem, interpersonal relationships,
and economic well-being may be adversely
affected when an individual is unable to main-
tain his current profession with the possible
loss of future earnings or forced early retire-
ment. These factors, among others, may lead
the health care worker to delay seeking much
needed medical attention (Charous et al.
2002a). In addition to eliminating exposure to
latex, the treatment for OA is the same as for
other types of asthma (Wild and Lopez  2003).
Workers with latex sensitization and latex-
induced OA should be counseled to wear a
MedicAlert bracelet and carry injectable epi-
nephrine with them at all times. They should
also be counseled as to what items contain
latex and to avoid dermal, mucosal, or serosal
contact with them (Howarth 2001).
Conclusion
This case describes a surgical pathologist whose
presentation is consistent with a diagnosis of
latex-induced OA. It shows how exposure to a
high-molecular-weight protein, latex, led to
ACD. Repeated exposure to the inciting agent
over a latency period of several years led to latex
sensitization and ultimately to latex-induced
OA in this atopic indiviual. He did not give a
clear history of anaphylaxis, but he was diag-
nosed with “near syncope” of unknown etiol-
ogy after ﬂipping his gloves off and placing his
hand over his nose and mouth, after which he
was returned to work without intervention.
Skin prick test, which is diagnostic for the
presence of IgE-mediated allergy to latex, was
positive to several latex-containing extracts.
Although his serum IgE, or RAST, to one type
of latex protein was negative, false-negative
tests do occur (Hamilton 1999). The patient’s
medical and occupational history, in combina-
tion with his spirometry and PEFR measure-
ments, supports the diagnosis of OA, reversible
airways disease responding to bronchodilators
with symptoms that are worse at work and
improve away from work. Formaldehyde and
xylene probably acted as irritants, exacerbating
his pulmonary symptoms.
The mainstay of treatment for latex-
induced OA is to prevent contact of the
worker with the inciting agents. Creating a
latex-safe environment is the provision of
choice (Charous et al. 2002b). However, this
provision was not made at the time. Given the
long period of the patient’s exposure and the
severity of his disease, there was concern that
his pulmonary function would continue to
decline with continued exposure and that he
was at risk for anaphylaxis. We thought
removal from the workplace was the best way
to protect the patient from exposure. Despite
removal from inciting agents, the patient’s
symptoms and pulmonary status did not
improve. He remains out of work and is main-
tained on steroids and immunosuppressive
agents. If his condition been identified and
removal from exposure occurred sooner, his
disease may not have progressed. Prompt iden-
tiﬁcation of latex allergy and sensitization, as
well as reduction or elimination of the hazard,
may allow the patient to continue working in
his environment and prevent progression of
disease. Clinicians should consider OA in
patients who present with new-onset asthma or
who present with asthma symptoms that
worsen during or after work.
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